These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 29581115)

  • 41. A multicentre study of antifungal susceptibility patterns among 350 Candida auris isolates (2009-17) in India: role of the ERG11 and FKS1 genes in azole and echinocandin resistance.
    Chowdhary A; Prakash A; Sharma C; Kordalewska M; Kumar A; Sarma S; Tarai B; Singh A; Upadhyaya G; Upadhyay S; Yadav P; Singh PK; Khillan V; Sachdeva N; Perlin DS; Meis JF
    J Antimicrob Chemother; 2018 Apr; 73(4):891-899. PubMed ID: 29325167
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Accuracy of Sensititre YeastOne echinocandins epidemiological cut-off values for identification of FKS mutant Candida albicans and Candida glabrata: a ten year national survey of the Fungal Infection Network of Switzerland (FUNGINOS).
    Kritikos A; Neofytos D; Khanna N; Schreiber PW; Boggian K; Bille J; Schrenzel J; Mühlethaler K; Zbinden R; Bruderer T; Goldenberger D; Pfyffer G; Conen A; Van Delden C; Zimmerli S; Sanglard D; Bachmann D; Marchetti O; Lamoth F;
    Clin Microbiol Infect; 2018 Nov; 24(11):1214.e1-1214.e4. PubMed ID: 29909005
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Echinocandin Resistance in Candida.
    Perlin DS
    Clin Infect Dis; 2015 Dec; 61 Suppl 6(Suppl 6):S612-7. PubMed ID: 26567278
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Candida guilliermondii, an opportunistic fungal pathogen with decreased susceptibility to fluconazole: geographic and temporal trends from the ARTEMIS DISK antifungal surveillance program.
    Pfaller MA; Diekema DJ; Mendez M; Kibbler C; Erzsebet P; Chang SC; Gibbs DL; Newell VA
    J Clin Microbiol; 2006 Oct; 44(10):3551-6. PubMed ID: 17021081
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The Role of Echinocandins in Candida Biofilm-Related Vascular Catheter Infections: In Vitro and In Vivo Model Systems.
    Ghannoum M; Roilides E; Katragkou A; Petraitis V; Walsh TJ
    Clin Infect Dis; 2015 Dec; 61 Suppl 6():S618-21. PubMed ID: 26567279
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Candida spp. with acquired echinocandin resistance, France, 2004-2010.
    Dannaoui E; Desnos-Ollivier M; Garcia-Hermoso D; Grenouillet F; Cassaing S; Baixench MT; Bretagne S; Dromer F; Lortholary O;
    Emerg Infect Dis; 2012 Jan; 18(1):86-90. PubMed ID: 22257484
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Risk factors of mortality and comparative in-vitro efficacy of anidulafungin, caspofungin, and micafungin for candidemia.
    Lee SC; Lee CW; Shih HJ; Huang SH; Chiou MJ; See LC
    J Microbiol Immunol Infect; 2014 Jun; 47(3):245-53. PubMed ID: 24246191
    [TBL] [Abstract][Full Text] [Related]  

  • 48. In vitro activity of echinocandins against non-Candida albicans: is echinocandin antifungal activity the same?
    Espinel-Ingroff A; Cantón E
    Enferm Infecc Microbiol Clin; 2011 Mar; 29 Suppl 2():3-9. PubMed ID: 21420570
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Species-specific differences in the susceptibilities of biofilms formed by Candida bloodstream isolates to echinocandin antifungals.
    Choi HW; Shin JH; Jung SI; Park KH; Cho D; Kee SJ; Shin MG; Suh SP; Ryang DW
    Antimicrob Agents Chemother; 2007 Apr; 51(4):1520-3. PubMed ID: 17283191
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Breakthrough fungemia due to Candida fermentati with fks1p mutation under micafungin treatment in a cord blood transplant recipient.
    Konuma T; Takahashi S; Kiyuna T; Miharu Y; Suzuki M; Shibata H; Kato S; Takahashi S; Tojo A
    Transpl Infect Dis; 2017 Feb; 19(1):. PubMed ID: 27859978
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Susceptibility of fluconazole-resistant clinical isolates of Candida spp. to echinocandin LY303366, itraconazole and amphotericin B.
    Cuenca-Estrella M; Mellado E; Díaz-Guerra TM; Monzón A; Rodríguez-Tudela JL
    J Antimicrob Chemother; 2000 Sep; 46(3):475-7. PubMed ID: 10980178
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Echinocandins: Their role in the management of
    Swaminathan S; Kamat S; Pinto NA
    Indian J Med Microbiol; 2018; 36(1):87-92. PubMed ID: 29735833
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Rapid development of Candida krusei echinocandin resistance during caspofungin therapy.
    Forastiero A; Garcia-Gil V; Rivero-Menendez O; Garcia-Rubio R; Monteiro MC; Alastruey-Izquierdo A; Jordan R; Agorio I; Mellado E
    Antimicrob Agents Chemother; 2015 Nov; 59(11):6975-82. PubMed ID: 26324281
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Impact of Micafungin on Candida auris β-glucan Masking and Neutrophil Interactions.
    Horton MV; Eix EF; Johnson CJ; Dean MEB; Andes BD; Wartman KM; Nett JE
    J Infect Dis; 2024 Sep; 230(3):763-767. PubMed ID: 38330449
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Comparison of broth microdilution and E-test methods for the antifungal susceptibility testing of Candida spp. strains isolated from blood cultures].
    Ozcan SK; Mutlu B; Dündar D; Willke A
    Mikrobiyol Bul; 2010 Apr; 44(2):263-71. PubMed ID: 20549961
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Next-generation sequencing offers new insights into the resistance of Candida spp. to echinocandins and azoles.
    Garnaud C; Botterel F; Sertour N; Bougnoux ME; Dannaoui E; Larrat S; Hennequin C; Guinea J; Cornet M; Maubon D
    J Antimicrob Chemother; 2015 Sep; 70(9):2556-65. PubMed ID: 26017039
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Frequency of the Paradoxical Effect Measured Using the EUCAST Procedure with Micafungin, Anidulafungin, and Caspofungin against Candida Species Isolates Causing Candidemia.
    Marcos-Zambrano LJ; Escribano P; Sánchez-Carrillo C; Bouza E; Guinea J
    Antimicrob Agents Chemother; 2017 Jan; 61(1):. PubMed ID: 27799221
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparison of the Sensititre YeastOne colorimetric antifungal panel with CLSI microdilution for antifungal susceptibility testing of the echinocandins against Candida spp., using new clinical breakpoints and epidemiological cutoff values.
    Pfaller MA; Chaturvedi V; Diekema DJ; Ghannoum MA; Holliday NM; Killian SB; Knapp CC; Messer SA; Miskou A; Ramani R
    Diagn Microbiol Infect Dis; 2012 Aug; 73(4):365-8. PubMed ID: 22726528
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Micafungin Breakthrough Fungemia in Patients with Hematological Disorders.
    Kimura M; Araoka H; Yamamoto H; Nakamura S; Nagi M; Yamagoe S; Miyazaki Y; Ogura S; Mitsuki T; Yuasa M; Kaji D; Kageyama K; Nishida A; Taya Y; Shimazu H; Ishiwata K; Takagi S; Yamamoto G; Asano-Mori Y; Uchida N; Wake A; Taniguchi S; Yoneyama A
    Antimicrob Agents Chemother; 2018 May; 62(5):. PubMed ID: 29530846
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparison of Killing Activity of Micafungin Against Six Candida Species Isolated from Peritoneal and Pleural Cavities in RPMI-1640, 10 and 30% Serum.
    Tóth Z; Kardos T; Kovács R; Kardos G; Nagy F; Prépost E; Barta Z; Takacs I; Majoros L
    Mycopathologia; 2018 Dec; 183(6):905-912. PubMed ID: 30382508
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.